Slideshow
Author(s):
Symptoms of sudden onset of headache and decreased balance three days earlier prompted a visit to the emergency department.
FDA Approves Expanded Age Indication for Nerivio Migraine Device in Pediatric Patients
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
FDA Action Update, October 2024: Approvals, Acceptance, and Hold Removal
Sleeping Around the Podcast × NeurologyLive: Calcitonin Gene-Related Peptide in Sleep Research
Combination of Migraine and Gestational Diabetes Poses Greater Risk for Premature Major Adverse Cardiovascular and Cerebrovascular Events
Nonopioid Medication Overuse Headache Remission Observed With Erenumab